Venlafaxine performed better for depression, achieving a greater sustained response rate during the maintenance phase than lithium
The authors conducted an open-label study of the efficacy and tolerability of venlafaxine and of lithium augmentation in
Muscionico S
Lithium’s tolerability is comparable to the atypicals, and its side effects are further reduced by starting low (150–300 mg) and raising slowly (every 5 days toward
In treatment of manic-depressive conditions long-term lithium therapy may be combined with an effective and relatively safe antidepressant venlafaxine
The battery cell formation is one of the most critical process steps in lithium-ion battery (LIB) cell production, because it affects the key battery performance metrics